core sessions

Plenary lectures

Referring to our congress motto three outstanding experts will address specific future perspectives in diagnosis, treatment, and prevention since Bleuler’s first mention of the term schizophrenia.

PLENARY LECTURE 1

23rd of September 2021

PFalkai

110 years of schizophrenia:
From phenomenology to neurobiology

PLENARY LECTURE 2

24th of September 2021

KBrennand

Pathways to the future: 
The promise of stem-cell biology in diagnosing, treating, and preventing schizophrenia

 

PLENARY LECTURE 3

25th of September 2021

CCorrell

Novel and emerging treatments
 for schizophrenia: Beyond postsynaptic dopamine receptor blockade

workshop

Priorities in future schizophrenia research
 

organized and chaired by
ESAS Executive Committee member 
Silvana Galderisi including views of:

Hilkka Kärkkäinen
President of GAMIAN Europe, Brussels, Belgium

Urs Würsch
President of EUFAMI, Leuven, Belgium

Michaela Amering
Vienna, Austria

Wulf Rössler
Zurich, Switzerland

Werner Strik
Bern, Switzerland

 

Debate

Should schizoaffective disorder be diagnosed cross-sectionally (ICD-11) instead of longitudinally (DSM-5)?

Peter Falkai 
Munich, Germany,
will represent the PRO position

PFalkai

moderated  by
ESAS Executive Committee member 
Silvana Galderisi:

Ingrid Melle, Oslo, Norway, 
will argue against the cross-sectional ICD-11-approach

PFalkai